GlassScriptPhysician profile
Peggy B Foster
NPI 1013023373
$3,359.39
in general payments reported to CMS, 2019-2025
16 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Psychiatric/Mental Health, Adult (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $174).
See the full distribution for Psychiatric/Mental Health, Adult (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $872 · 2023: $813 · 2024: $651 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $651.57 | 2021-2024 | |
| Alkermes, INC. | $535.75 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Teva Pharmaceuticals USA, INC. | $309.29 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $279.91 | 2022-2025 | Caplyta |
| Indivior INC. | $278.74 | 2022-2025 | Sublocade, Perseris |
| Neurocrine Biosciences, INC. | $242.36 | 2022-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $205.83 | 2022-2025 | Hetlioz, Fanapt |
| Axsome Therapeutics, INC. | $203.57 | 2022-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $193.35 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Lundbeck LLC | $156.73 | 2021-2024 | Abilify Maintena |
| Janssen Pharmaceuticals, INC | $132.05 | 2021-2025 | Invega Sustenna |
| Sunovion Pharmaceuticals INC. | $114.63 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.25 | 2025 | Cobenfy |
| Idorsia Pharmaceuticals US INC | $14.91 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $12.41 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.